199 related articles for article (PubMed ID: 18715778)
21. Identification and clinical validation of a multigene assay that interrogates the biology of cancer stem cells and predicts metastasis in breast cancer: A retrospective consecutive study.
Pece S; Disalvatore D; Tosoni D; Vecchi M; Confalonieri S; Bertalot G; Viale G; Colleoni M; Veronesi P; Galimberti V; Di Fiore PP
EBioMedicine; 2019 Apr; 42():352-362. PubMed ID: 30846393
[TBL] [Abstract][Full Text] [Related]
22. Long-term impact of the 70-gene signature on breast cancer outcome.
Drukker CA; van Tinteren H; Schmidt MK; Rutgers EJ; Bernards R; van de Vijver MJ; Van't Veer LJ
Breast Cancer Res Treat; 2014 Feb; 143(3):587-92. PubMed ID: 24445566
[TBL] [Abstract][Full Text] [Related]
23. A gene signature for late distant metastasis in breast cancer identifies a potential mechanism of late recurrences.
Mittempergher L; Saghatchian M; Wolf DM; Michiels S; Canisius S; Dessen P; Delaloge S; Lazar V; Benz SC; Tursz T; Bernards R; van't Veer LJ
Mol Oncol; 2013 Oct; 7(5):987-99. PubMed ID: 23910573
[TBL] [Abstract][Full Text] [Related]
24. A gene expression signature identifies two prognostic subgroups of basal breast cancer.
Sabatier R; Finetti P; Cervera N; Lambaudie E; Esterni B; Mamessier E; Tallet A; Chabannon C; Extra JM; Jacquemier J; Viens P; Birnbaum D; Bertucci F
Breast Cancer Res Treat; 2011 Apr; 126(2):407-20. PubMed ID: 20490655
[TBL] [Abstract][Full Text] [Related]
25. Identification of a prognostic LncRNA signature for ER-positive, ER-negative and triple-negative breast cancers.
Liu D
Breast Cancer Res Treat; 2020 Aug; 183(1):95-105. PubMed ID: 32601968
[TBL] [Abstract][Full Text] [Related]
26. Prognostic breast cancer signature identified from 3D culture model accurately predicts clinical outcome across independent datasets.
Martin KJ; Patrick DR; Bissell MJ; Fournier MV
PLoS One; 2008 Aug; 3(8):e2994. PubMed ID: 18714348
[TBL] [Abstract][Full Text] [Related]
27. Subtype-specific prognostic impact of different immune signatures in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Elger T; Krajnak S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
Breast Cancer Res Treat; 2017 Sep; 165(2):293-300. PubMed ID: 28585074
[TBL] [Abstract][Full Text] [Related]
28. Prognostic relevance of carcinoembryonic antigen and estrogen receptor status in breast cancer patients.
Esteban JM; Felder B; Ahn C; Simpson JF; Battifora H; Shively JE
Cancer; 1994 Sep; 74(5):1575-83. PubMed ID: 7914825
[TBL] [Abstract][Full Text] [Related]
29. Systematic assessment of prognostic gene signatures for breast cancer shows distinct influence of time and ER status.
Zhao X; Rødland EA; Sørlie T; Vollan HK; Russnes HG; Kristensen VN; Lingjærde OC; Børresen-Dale AL
BMC Cancer; 2014 Mar; 14():211. PubMed ID: 24645668
[TBL] [Abstract][Full Text] [Related]
30. Population-based molecular prognosis of breast cancer by transcriptional profiling.
Ma Y; Qian Y; Wei L; Abraham J; Shi X; Castranova V; Harner EJ; Flynn DC; Guo L
Clin Cancer Res; 2007 Apr; 13(7):2014-22. PubMed ID: 17404081
[TBL] [Abstract][Full Text] [Related]
31. A specific gene expression signature for visceral organ metastasis in breast cancer.
Savci-Heijink CD; Halfwerk H; Koster J; Horlings HM; van de Vijver MJ
BMC Cancer; 2019 Apr; 19(1):333. PubMed ID: 30961553
[TBL] [Abstract][Full Text] [Related]
32. Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures.
Chen J; Sam L; Huang Y; Lee Y; Li J; Liu Y; Xing HR; Lussier YA
J Biomed Inform; 2010 Jun; 43(3):385-96. PubMed ID: 20350617
[TBL] [Abstract][Full Text] [Related]
33. Identification of a New Eight-Long Noncoding RNA Molecular Signature for Breast Cancer Survival Prediction.
Zhang Y; Li Z; Chen M; Chen H; Zhong Q; Liang L; Li B
DNA Cell Biol; 2019 Dec; 38(12):1529-1539. PubMed ID: 31647329
[TBL] [Abstract][Full Text] [Related]
34. Next generation sequencing-based expression profiling identifies signatures from benign stromal proliferations that define stromal components of breast cancer.
Guo X; Zhu SX; Brunner AL; van de Rijn M; West RB
Breast Cancer Res; 2013 Dec; 15(6):R117. PubMed ID: 24342436
[TBL] [Abstract][Full Text] [Related]
35. A qualitative transcriptional signature to reclassify histological grade of ER-positive breast cancer patients.
Li J; Jiang W; Liang Q; Liu G; Dai Y; Zheng H; Yang J; Cai H; Zheng G
BMC Genomics; 2020 Apr; 21(1):283. PubMed ID: 32252627
[TBL] [Abstract][Full Text] [Related]
36. RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype.
Habashy HO; Powe DG; Glaab E; Ball G; Spiteri I; Krasnogor N; Garibaldi JM; Rakha EA; Green AR; Caldas C; Ellis IO
Breast Cancer Res Treat; 2011 Jul; 128(2):315-26. PubMed ID: 20697807
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of public cancer datasets and signatures identifies TP53 mutant signatures with robust prognostic and predictive value.
Lehmann BD; Ding Y; Viox DJ; Jiang M; Zheng Y; Liao W; Chen X; Xiang W; Yi Y
BMC Cancer; 2015 Mar; 15():179. PubMed ID: 25886164
[TBL] [Abstract][Full Text] [Related]
38. Gene expression profiling to predict the risk of locoregional recurrence in breast cancer: a pooled analysis.
Drukker CA; Elias SG; Nijenhuis MV; Wesseling J; Bartelink H; Elkhuizen P; Fowble B; Whitworth PW; Patel RR; de Snoo FA; van 't Veer LJ; Beitsch PD; Rutgers EJ
Breast Cancer Res Treat; 2014 Dec; 148(3):599-613. PubMed ID: 25414025
[TBL] [Abstract][Full Text] [Related]
39. Gene expression profiles associated with the presence of a fibrotic focus and the growth pattern in lymph node-negative breast cancer.
Van den Eynden GG; Smid M; Van Laere SJ; Colpaert CG; Van der Auwera I; Bich TX; van Dam P; den Bakker MA; Dirix LY; Van Marck EA; Vermeulen PB; Foekens JA
Clin Cancer Res; 2008 May; 14(10):2944-52. PubMed ID: 18483361
[TBL] [Abstract][Full Text] [Related]
40. A core invasiveness gene signature reflects epithelial-to-mesenchymal transition but not metastatic potential in breast cancer cell lines and tissue samples.
Marsan M; Van den Eynden G; Limame R; Neven P; Hauspy J; Van Dam PA; Vergote I; Dirix LY; Vermeulen PB; Van Laere SJ
PLoS One; 2014; 9(2):e89262. PubMed ID: 24586640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
